Company REFS has been acquired by Stockopedia & Slater Investments - Read the Press Release

Uncover High Growth Stocks With The New Home For Company REFS Subscribers

A personal message from Stockopedia CEO Ed Croft - a former Company REFS Subscriber

Take your 14 day risk-free trial with a 25% first year discount to reveal which low PEG Growth Stocks are qualifying for the rules of the Zulu Principle today
Yes, I'd Like To Claim My 14 Day Trial & Introductory Discount

After your free trial you'll pay just £198.75 for the first year of your UK plan. With a 30 day money back guarantee there's absolutely no risk.

Here’s what you’ll get from your Stockopedia trial

An online Stock Analysis, Screening & Portfolio Tracking Service, originally inspired by the work of Company REFS

Thousands of StockReports across UK and global shares including all the essential statistics in a familiar 1 page format - described as “an absolute delight” by David Stevenson in the Financial Times.

Access to hundreds of financial ratios, calculated daily, that include Slater-inspired "Rolling" Forecast PE, EPS Growth and Yield Data, including the all-important PEG

A powerful Stock Screener with more than 65 expert investment strategies including a screen using the Zulu Principle rules - the top performing Growth Strategy over the last 6 years.

StockRanks that reveal the Quality, Value and Momentum of every stock in the market, providing an instant numeric assessment of market beating potential. It’s this feature that 73% of Stockopedia subscribers said was most helpful in generating their above market returns in the last year.

Easy to use RiskRatings to help you avoid the highly speculative end of the market.

A Style Classification for every stock so you can instantly separate the Value Traps from the Turnarounds.

An active community of more than 10,000 private investors, helping you find inspiration and investment ideas.

The ability to expand your search for growth stocks beyond the confinements of the UK. Find low PEG Stocks all over Europe and the USA for less than the cost of a REFS Subscription.

Daily market comment from award-winning bloggers and educational research features to help you understand and profit from the market.

All of this from just £265 per year
Saving well over £555 per year vs a Company REFS subscription
Begin My 14 Day Trial

After your free trial you'll pay a discounted rate of just £198.75 for the first year of your UK plan. With a 30 day money back guarantee there's absolutely no risk.

Hear what our subscribers have to say about Stockopedia

Learn how Stockopedia has transformed the results of these real investors

When you make decisions aided by data, you have to be able to trust the quality and timeliness. Here's how we do it.


Our primary source, Thomson Reuters, employs thousands of analysts who scan, audit & standardise financial data entry into their databases before uploading to their financial cloud.


Throughout the day and night we download these financial statements, analyst estimate data, price quotes & histories and other company information to our databases.


After organising it and cleaning it all up, we then crunch over 60 million computations to build up a library of essential, accurate and timely statistics on every stock. From simple PE Ratios to Piotroski F-Scores.


We then rank and screen the market to filter the wheat from the chaff. The output is then published in brilliant StockReports, GuruScreens, StockRanks and Chart Signals to improve your stock market odds.

Our data is designed for individual investors in partnership with
Thomson Reuters is the data-supplier to Stockopedia

Stockopedia is one of the few companies in the world that the markets giant Thomson Reuters partners with to serve the individual investor.

The Stockopedia service has been widely acclaimed by financial press, investor associations and famous influencers

"Stockopedia has always been miles ahead in its presentation of data and its carefully selected use of stock screens to identify great stocks."

David Stevenson
Financial Times Review

"Expensive fund managers should be looking over their shoulders."

Andrew Oxlade
The Telegraph Review

"Since I last wrote about advanced screeners for value investors Stockopedia has emerged as my favourite. For data, Stockopedia shines."

Richard Beddard
Interactive Investor Review

"Stockopedia presents all the data on any company that you are likely to want, saving you doing the analysis - this is a highly recommended service."

Roger Lawson
Sharesoc Review

"One of the advantages of using Stockopedia is that it helps throw up companies that you would otherwise not find out about. It also helps investors avoid getting caught in the traps that even the biggest household name shares can lay."

Simon Lambert
This is Money / Daily Mail Review

"Stockopedia is a great place to scan for new shares to buy. Each share gets a ranking, you can use 'guru' screens to find shares, there is even a stock screen loosely based on my criteria! There is lots more really fantastic material and I believe access should help investors and I now use it myself."

Robbie Burns
The Naked Trader Review
Begin My 14 Day Trial

After your free trial you'll pay a discounted rate of just £198.75 for the first year of your UK plan. With a 30 day money back guarantee there's absolutely no risk.

Grow in confidence and self-reliance with the support of an exceptionally well informed community of investors

67% have outperformed the market since subscribing
75% have grown in confidence since subscribing
Same confidence
More confidence

*December 2017 survey of Stockopedia Subscribers.

I want to thank all the Stockopedia team for this excellent website and I also want to thank YOU too. The Stockopedia community are a brilliant bunch. So much insight and knowledge; it certainly helps to form a 360 degree view of a stock when there are so many well informed opinions from well respected investors.
Private Investor

Still have Questions?

What's happened to Company REFS?

Company REFS got into financial difficulties and ended up going into liquidation. Slater Investments & made a joint bid for the assets of Company REFS. You can read the press release here

What's happened to my Company REFS subscription?

Unfortunately your access to Company REFS has ended when the company went into liquidation. We are unable to provide any continuation of this service or provide refunds. However if you are a former Company REFS subscriber, you can login here to claim your 3 months free Stockopedia access.

If I find that Stockopedia is not for me how do I cancel?

We're confident that you'll love the Stockopedia platform but if you find it's not for you, cancelling is easy and can be done directly within the platform. Not only will you have a 2 week free trial, you'll also benefit from our 30 day money-back guarantee giving you complete peace of mind.

Where can I find out more about Stockopedia

We provide a host of information on our website. Including a rundown of all our features, a history of the company, 100's of customer reviews, tonnes of learning materials and so much more...

A subscription to Stockopedia will be one of the best investments you'll ever make...

Here's what you'll get:
A decade of research into what works in stock markets
Millions of pounds of platform investment
Countless hours of research time saved
Access to hundreds of educational articles and ebooks
A 25 strong team of professionals working flat out for you
A team of the very best bloggers acting as mentors
Saving you thousands in advisory fees every year
Give it a try for just £198.75

Stockopedia is the perfect solution for the time-poor individual investor looking for results

Begin My 14 Day Trial

After your free trial you'll pay just £198.75 for the first year of your UK plan. With a 30 day money back guarantee there's absolutely no risk.

© Stockopedia , Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.